Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · IEX Real-Time Price · USD
2.900
-0.040 (-1.36%)
Jul 19, 2024, 4:30 PM EDT - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 862 employees as of December 31, 2023. The number of employees decreased by 168 or -16.31% compared to the previous year.
Employees
862
Change (1Y)
-168
Growth (1Y)
-16.31%
Revenue / Employee
$505,190
Profits / Employee
$6,746
Market Cap
384.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Revance Therapeutics | 597 |
| uniQure | 480 |
| AxoGen | 428 |
| Lyell Immunopharma | 224 |
| Sight Sciences | 214 |
| Precigen | 202 |
| Lexeo Therapeutics | 58 |
| Tourmaline Bio | 44 |
ORGO News
- 6 days ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024 - GlobeNewsWire
- 6 weeks ago - Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference - GlobeNewsWire
- 2 months ago - Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee Osteoarthritis - GlobeNewsWire
- 3 months ago - Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024 - GlobeNewsWire
- 3 months ago - Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case - GlobeNewsWire
- 5 months ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance - GlobeNewsWire
- 5 months ago - Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference - GlobeNewsWire
- 5 months ago - Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024 - GlobeNewsWire